Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Market Cap

Lexaria Bioscience has a market cap or net worth of $14.75 million as of July 13, 2026. Its market cap has decreased by -2.34% in one year.

• Market Cap: 14.75M
• Enterprise Value: 9.57M
• 1-Year Change: -2.34%
• Ranking: #5087
• Category: Nano-Cap
• Stock Price: $0.59

Market Cap Chart

Since February 12, 2007, Lexaria Bioscience's market cap has decreased from $19.40M to $14.75M, a decrease of -23.99%. That is a compound annual growth rate of -1.40%.

Market Cap History

Date	Market Cap	% Change
Jul 13, 2026	14.70M	7.30%
Dec 31, 2025	13.70M	-62.67%
Dec 31, 2024	36.70M	186.72%
Dec 29, 2023	12.80M	-12.33%
Dec 30, 2022	14.60M	-36.80%
Dec 31, 2021	23.10M	2.67%
Dec 31, 2020	22.50M	-24.75%
Dec 31, 2019	29.90M	-58.30%
Dec 31, 2018	71.70M	-38.87%
Dec 29, 2017	117.30M	624.07%
Dec 30, 2016	16.20M	131.43%
Dec 31, 2015	7.00M	125.81%
Dec 31, 2014	3.10M	342.86%
Dec 31, 2013	700.00K	-12.50%
Dec 31, 2012	800.00K	-77.78%
Dec 30, 2011	3.60M	-7.69%
Dec 31, 2010	3.90M	69.57%
Dec 31, 2009	2.30M	130.00%
Dec 31, 2008	1.00M	-94.71%
Dec 31, 2007	18.90M	-2.58%
Feb 12, 2007	19.40M	-

View and export this data all the way back to 2007. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jul 13, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jul 13, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Pasithea Therapeutics	16.37M
Cyclerion Therapeutics	16.20M
Vyome Holdings	15.72M
Moolec Science	15.44M
Citius Pharmaceuticals	14.82M
Tempest Therapeutics	14.56M
Passage Bio	14.31M
GT Biopharma	13.98M